MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.clml.2026.01.016

Медицинская библиотека · Clinical lymphoma, myeloma & leukemia · 2026

Real-World Insights Into Acute promyelocytic leukemia (APL) in Egypt in the Absence of Arsenic Trioxide (ATO): Clinical Characteristics, Outcomes and Risk Factors for Early Mortality: A Single Center Study.

Shaaban Yasmine, Laimon Dina N, Jamal Esraa

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Acute promyelocytic leukemia (APL) is a rare but highly curable subtype of acute leukemia. Despite therapeutic advances, early death (ED) within 30 days of diagnosis remains a major challenge affecting APL outcomes. In this study, the clinical, laboratory and treatment parameters were assessed and causes and risk factors for ED and non-ED were investigated and compared in a cohort of APL patients.

PATIENTS AND

METHODS

This is a real-world retrospective study of 110 newly diagnosed APL patients who were diagnosed and treated at oncology center, Mansoura university between March 2011 and January 2025.

RESULTS

The median overall survival of 36.8 months reflects the heterogeneity of disease presentation and treatment response. Life-threatening thrombo-hemorrhagic events during the disease course particularly intracranial hemorrhage and severe thrombotic complications were associated with significantly poorer outcomes. ED occurred in 26 patients at a median of 17 days after diagnosis. Differentiation syndrome (DS) was the commonest cause of ED followed by hemorrhage and multiorgan failure. Univariate analysis associated ED with the older adults, leukocytosis, elevated neutrophil-lymphocyte ratio (NLR ≥ 0.28), thrombocytopenia, hypoalbuminemia, and elevated creatinine (> 1.2 mg/dL). Multivariate analysis identified age ≥ 38 years, leukocytosis (≥ 20 × 109/L), NLR ≥ 0.28, thrombocytopenia (≤ 50 × 109/L), and hypoalbuminemia as independent predictors of ED. Pulmonary complications during DS, elevated LDH, and renal dysfunction lacked 30-day prognostic significance.

CONCLUSION

Real-world results estimated the incidence of ED at higher rates than clinical trials do. Early recognition and modification of prognostic factors, particularly DS management and supportive care, are essential to reduce ED and improve survival outcomes in APL.

Для цитирования: Shaaban Yasmine, Laimon Dina N, Jamal Esraa. Real-World Insights Into Acute promyelocytic leukemia (APL) in Egypt in the Absence of Arsenic Trioxide (ATO): Clinical Characteristics, Outcomes and Risk Factors for Early Mortality: A Single Center Study.. Clinical lymphoma, myeloma & leukemia. 2026. DOI: 10.1016/j.clml.2026.01.016.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.